Company Filing History:
Years Active: 2022-2025
Title: Innovations of Tomohiro Nishimura
Introduction
Tomohiro Nishimura is a prominent inventor based in Kumamoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of five patents to his name, Nishimura's work focuses on preventing and treating infections caused by cytomegalovirus (CMV).
Latest Patents
Nishimura's latest patents include a vaccine designed to prevent or treat congenital infection with cytomegalovirus. This innovative vaccine comprises a CMV envelope glycoprotein B (gB protein) antigen and a pentamer antigen. Another notable patent involves a modified CMV gB protein that can induce a high ratio of neutralizing antibodies, which exhibit enhanced neutralizing activity against CMV. This modified protein is aimed at improving the prevention and treatment of CMV infections.
Career Highlights
Throughout his career, Nishimura has been associated with Km Biologics Co., Ltd., where he has been instrumental in advancing vaccine technology. His research has focused on enhancing the efficacy of vaccines against viral infections, particularly CMV.
Collaborations
Nishimura has collaborated with notable colleagues such as Hiroaki Mori and Hiroyuki Shimizu. These collaborations have contributed to the development of innovative solutions in the field of virology.
Conclusion
Tomohiro Nishimura's work in vaccine development showcases his commitment to addressing significant health challenges. His innovative patents reflect a dedication to improving public health through advanced biotechnology.